|
Age
yr
|
71.3 ± 11.9
|
72.0 ± 8.9
|
ns
|
|
Male sex
no. (%)
|
77 (53.8)
|
71 (71.0)
|
<0.01
|
|
Coexisting conditions
no. (%)
|
|
Smoker
|
47 (32.9)
|
45 (45.0)
|
ns
|
|
pack years
|
44.4 ± 19.6
|
57.6 ± 23.1
|
ns
|
|
Hypertension
|
130 (90.9)
|
86 (86.0)
|
ns
|
|
Diabetes
|
54 (37.8)
|
32 (32.0)
|
ns
|
|
HbA1c %
|
6.9 ± 1.6
|
6.6 ± 1.8
|
ns
|
|
Dyslipidaemia
|
86 (60.1)
|
52 (52.0)
|
ns
|
|
Cholesterol totalmmol/L
|
4.5 ± 1.2
|
4.6 ± 1.5
|
ns
|
|
LDL cholesterolmmol/L
|
2.7 ± 1.0
|
3.1 ± 1.3
|
ns
|
|
CVD
|
83 (58.0)
|
53 (53.0)
|
ns
|
|
eGFR (EPI)
ml/min/1.73 m2
|
<15
|
67.2 ± 23.9
|
-
|
|
Proteinuria
mg/mmol
|
No data
|
23 ± 47
|
-
|
|
Anti-hypertensive therapy
no. (%)
|
|
RAAS-inhibitors
|
64 (44.8)
|
64 (64.0)
|
<0.01
|
|
Calcium-antagonists
|
48 (33.6)
|
30 (30.0)
|
ns
|
|
Beta-blockers
|
61 (42.7)
|
35 (35.0)
|
ns
|
|
Alpha-blockers
|
29 (20.3)
|
4 (4.0)
|
<0.01
|
|
Diuretics
|
72 (50.3)
|
43 (43.0)
|
ns
|
|
Follow-up
months
|
16.4 ± 7.5
|
0
|
-
|
|
Duration of dialysis
months
|
40.3 ± 35.2
|
-
|
-
|
|
Kt/V
|
1.47 ± 0.33
|
-
|
-
|
|
Haemodynamics measuresmean ± SD
|
|
Systolic Pressure (peripheral)mmHg
|
126.2 ± 22.9
|
128.7 ± 17.5
|
ns
|
|
Diastolic Pressure (peripheral)mmHg
|
74.8 ± 14.0
|
78.4 ± 12.5
|
<0.05
|
|
Systolic Pressure (central)mmHg
|
114.8 ± 21.1
|
117.8 ± 16.6
|
ns
|
|
Diastolic Pressure (central)mmHg
|
76.5 ± 14.1
|
79.9 ± 12.6
|
0.05
|
|
Peripheral resistancess*mmHg/ml
|
1.4 ± 0.3
|
1.4 ± 0.2
|
ns
|
|
Cardiac output
l/min
|
3.8 ± 0.6
|
3.9 ± 0.6
|
ns
|
|
Pulse Pressure
mmHg
|
51.3 ± 15.1
|
50.3 ± 12.0
|
ns
|
|
Diabetics
|
53.5 ± 10.5
|
54.6 ± 12.9
|
ns
|
|
non-Diabetics
|
50.0 ± 17.2
|
48.3 ± 11.2
|
ns
|
|
CVD
|
50.8 ± 14.4
|
49.5 ± 12.1
|
ns
|
|
non-CVD
|
52.0 ± 16.2
|
51.1 ± 12.0
|
ns
|
|
Alx@75
%
|
25.1 ± 10.6
|
29.6 ± 10.0
|
<0.01
|
|
Refl. Coef.
%
|
63.1 ± 7.5
|
64.8 ± 6.3
|
ns (0.06)
|
|
MobPWV adjusted m/s
|
7.6 ± 2.1
|
6.4 ± 1.5
|
<0.01
|
|
Diabetics
|
7.9 ± 1.9
|
6.5 ± 1.5
|
<0.01
|
|
non-Diabetics
|
7.5 ± 2.2
|
6.4 ± 1.6
|
<0.01
|
|
CVD
|
7.8 ± 2.2
|
6.7 ± 1.4
|
<0.01
|
|
non- CVD
|
7.4 ± 2.0
|
6.1 ± 1.6
|
<0.01
|
|
MobPWV unadjusted m/s
|
10.6 ± 2.2
|
10.5 ± 1.7
|
ns
|
|
Diabetics
|
10.9 ± 2.0
|
10.7 ± 1.7
|
ns
|
|
non-Diabetics
|
10.5 ± 2.3
|
10.4 ± 1.7
|
ns
|
|
CVD
|
10.7 ± 2.3
|
10.8 ± 1.7
|
ns
|
|
non-CVD
|
10.5 ± 2.1
|
10.2 ± 1.6
|
ns
|
|
Labor resultsmean ± SD
|
|
Ionized calcium
mmol/l
|
1.15 ± 0.09
|
No data
| |
|
Diabetics
|
1.14 ± 0.08
| | |
|
non-Diabetics
|
1.16 ± 0.09
| | |
|
CVD
|
1.15 ± 0.09
| | |
|
non-CVD
|
1.15 ± 0.09
| | |
|
PTH
pmol/l
|
28.9 ± 21.0
|
No data
| |
|
Diabetics
|
26.1 ± 20.8
| | |
|
non-Diabetics
|
30.6 ± 21.0
| | |
|
CVD
|
28.8 ± 22.6
| | |
|
non-CVD
|
29.0 ± 18.7
| | |
|
Phosphate
mmol/L
|
1.59 ± 0.44
| | |
|
Bicarbonate
mmol/L
|
18.7 ± 8.1
| | |
